Straume et al. suggested that suppression of Hsp27 in breast cancer cells led to a decrease in the expression of VEGF-A, VEGF-C, and basic fibroblast growth factor through downregulation of NF-κB and STAT3, thus highlighting the Hsp27’s proangiogenic role [63]. This evidence concerns the gene HSPB1 and breast carcinoma.